Meet the Authors

Successful Launch of Phase 3 Asset in Different Therapeutic Areas


Herspiegel worked with their cross-functional client team to build and maintain a highly complex project plan and launch strategy for a Phase 3 asset in two different therapeutic areas. The strategy needed to take account of a rapidly changing and increasingly competitive market.

The Problem

A client recently acquired a Phase 3 asset, that needed to be launched in two separate therapeutic areas, within 6 months of each other. Their commercialization team needed to establish a process to identify and collate market insights and pressure test launch strategies for both therapeutic areas. They also needed to develop robust launch plans with various scenarios built-in and begin executing with a resource plan that involved stakeholders with varying priorities.

Our Solution

• Herspiegel compiled existing primary/secondary research to help refine the overall strategies around each launch.

• Facilitated workshops around the clinical data and key launch strategies to pressure test them among a team of internal and external experts.

• Collaboratively developed, refined, and socialized an integrated cross-functional US launch plan for launches in both therapeutic areas with all key stakeholders.

• Established a governance process for the product launches; managing project workstreams and teams to ensure rapid and seamless integration of internal and external stakeholders with timely updates to senior management.

Value Delivered

• Successful launch strategies that offered proper direction to a team with many competing priorities.

• Supplied clear and concise project plans detailing strategy, key initiatives, and tactics ensuring both alignment and coordination.

• Successful launches within both therapeutic areas with the brand exceeding first year and second-year goals by more than 25%.

Do you want to assess your launch readiness?

We have experience in more than 75 launches, spanning cell & gene therapy, oncology, rare disease, diabetes, obesity, infectious disease, CNS and trauma.

Meet the Authors

Let's Talk

Herspiegel is a leading professional services firm helping biotech start-ups and the world’s largest pharmaceutical companies navigate the path from science to brand performance and change patients’ lives. We are committed to using strategic insights from medical to commercial to market access to solve critical problems.